First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.

Wohlfarth, Ariane; Pang, Shaokun; Zhu, Mingshe; Gandhi, Adarsh S; Scheidweiler, Karl B; Liu, Hua-fen; Huestis, Marilyn A

Wohlfarth, Ariane; Pang, Shaokun; Zhu, Mingshe; Gandhi, Adarsh S; Scheidweiler, Karl B; Liu, Hua-fen; Huestis, Marilyn A.

Affiliation

Wohlfarth A; Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD;

Clin Chem ; 59(11): 1638-48, 2013 Nov.

Article in En | MEDLINE | ID: mdl-24014837

Subject(s)

Cannabinoids/metabolism; Designer Drugs/metabolism; Hepatocytes/metabolism; Humans; In Vitro Techniques; Mass Spectrometry/methods

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cannabinoids / Designer Drugs / Hepatocytes Limits: Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cannabinoids / Designer Drugs / Hepatocytes Limits: Humans Language: En Year: 2013 Type: Article